# Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA

> **NCT06091085** · PHASE1,PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 36 (estimated)

## Conditions studied

- OSA

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06091085
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-31
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091085, "Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06091085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*